Thursday, February 14, 2013

indicate Medicated bath foam bath King Cool (Asotopakku) 20 input tabletMy pal discuss to me about Medicated bath foam bath King Cool (Asotopakku) 20 input tablet and he suggest the capability is Medicated bath foam bath King Cool (Asotopakku) 20 input tablet. When I understand my chum impart about the specification of the product. In the morning, I determine to dispend Medicated bath foam bath King Cool (Asotopakku) 20 input tablet. Right subsequent using this good, I am greatly congenial. Details of regard are represent below.

Product Description

"Medicated bath foam bath King Cool (Asotopakku) 20 input tablet" is a medicated bath fizz tablet, you can enjoy 4 kinds of fragrance and colors of the hot water according to your feeling of the day. It is blended with Acopic, effective to improve lassitude in hot summer, sensitivity to cold feet and hands of carbon dioxide gas. Heat rash to be sweaty season, eczema, etc. Since the menthol is mixed in this product, you can have the cool and refreshing feeling after taking a bath while your skin is being cooled down. Trehalose Contains. It gives moisture to the tired skin due to the sunlight in the summer. The product is a fine-textured foam type, with no fragrance, colour or Paraben. It is a non-medicinal product with mild acidity.


╬ If you try this, you will be satisfied Medicated bath foam bath King Cool (Asotopakku) 20 input tablet. I think this is excellent. I grant 5 super stars to this products


Medicated bath foam bath King Cool (Asotopakku) 20 input tablet

Detail image Medicated bath foam bath King Cool (Asotopakku) 20 input tabletIf you want to know more details of this item, you can click link in frame below.

  • Japanese retail packaging ( Manual and instruction, if any, are in Japanese only. )
  • Net weight: 4 types * 5 tablets
  • Size (exterior): 156 * 90 * 105 (mm)



Item Tag: Medicated bath foam bath King Cool (Asotopakku) 20 input tablet, Inexpensive Medicated bath foam bath King Cool (Asotopakku) 20 input tablet

0 comments:

Post a Comment